These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19027116)

  • 1. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
    Rajendran S; Willoughby SR; Chan WP; Liberts EA; Heresztyn T; Saha M; Marber MS; Norman RJ; Horowitz JD
    Atherosclerosis; 2009 Jun; 204(2):509-14. PubMed ID: 19027116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature aging of cardiovascular/platelet function in polycystic ovarian syndrome.
    Chan WP; Ngo DT; Sverdlov AL; Rajendran S; Stafford I; Heresztyn T; Chirkov YY; Horowitz JD
    Am J Med; 2013 Jul; 126(7):640.e1-7. PubMed ID: 23688663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.
    Türkçüoğlu I; Engin-Üstün Y; Turan F; Kali Z; Karabulut AB; Meydanli M; Kafkasli A
    Gynecol Endocrinol; 2011 Sep; 27(9):609-14. PubMed ID: 20695761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
    Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
    BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
    Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
    J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.
    Kuşçu NK; Var A
    Acta Obstet Gynecol Scand; 2009; 88(5):612-7. PubMed ID: 19308750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure.
    Ellis GR; Anderson RA; Chirkov YY; Morris-Thurgood J; Jackson SK; Lewis MJ; Horowitz JD; Frenneaux MP
    J Cardiovasc Pharmacol; 2001 May; 37(5):564-70. PubMed ID: 11336107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
    Kahal H; Aburima A; Ungvari T; Rigby AS; Dawson AJ; Coady AM; Vince RV; Ajjan RA; Kilpatrick ES; Naseem KM; Atkin SL
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):252-8. PubMed ID: 23278130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
    Tarkun I; Arslan BC; Cantürk Z; Türemen E; Sahin T; Duman C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular function in the diagnostic categories of polycystic ovary syndrome.
    Moran LJ; Cameron JD; Strauss BJ; Teede HJ
    Hum Reprod; 2011 Aug; 26(8):2192-9. PubMed ID: 21616917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.
    Karadeniz M; Erdoğan M; Tamsel S; Zengi A; Alper GE; Cağlayan O; Saygili F; Yilmaz C
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):231-5. PubMed ID: 18393129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D.
    Ngo DT; Chan WP; Rajendran S; Heresztyn T; Amarasekera A; Sverdlov AL; O'Loughlin PD; Morris HA; Chirkov YY; Norman RJ; Horowitz JD
    Nitric Oxide; 2011 Oct; 25(3):326-30. PubMed ID: 21741493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.
    Tarkun I; Cetinarslan B; Türemen E; Sahin T; Cantürk Z; Komsuoglu B
    Eur J Endocrinol; 2005 Jul; 153(1):115-21. PubMed ID: 15994753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of occurrence of aortic sclerosis in an aging population.
    Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.